Northwest Biotherapeutics reported $-27.18M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Agenus USD -10.63M 74.49M Dec/2025
AstraZeneca USD 3.08B 754M Mar/2026
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Celldex Therapeutics USD -78.68M 2.63M Mar/2026
Eisai JPY -3.25B 20.43B Mar/2026
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Merck USD -4.24B 7.2B Mar/2026
Northwest Biotherapeutics USD -27.18M 7.81M Sep/2025
Pfizer USD 2.69B 4.34B Mar/2026
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025